{
    "organizations": [],
    "uuid": "38ae0c791b01a20473fd7da29b5e3ce7e94f531e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-protagonist-therapeutics-granted-t/brief-protagonist-therapeutics-granted-two-new-us-patents-for-peptide-drug-candidates-ptg-100-and-ptg-300-idUSFWN1OZ0PS",
    "ord_in_thread": 0,
    "title": "BRIEF-Protagonist Therapeutics Granted Two New US Patents For Peptide Drug Candidates PTG-100 And PTG-300",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 1:24 PM / Updated 11 minutes ago BRIEF-Protagonist Therapeutics Granted Two New US Patents For Peptide Drug Candidates PTG-100 And PTG-300 Reuters Staff 1 Min Read \nJan 4 (Reuters) - Protagonist Therapeutics Inc: \n* PROTAGONIST THERAPEUTICS GRANTED TWO NEW US PATENTS FOR PEPTIDE DRUG CANDIDATES PTG-100 AND PTG-300 Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T15:24:00.000+02:00",
    "crawled": "2018-01-04T15:39:55.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "granted",
        "two",
        "new",
        "u",
        "patent",
        "peptide",
        "drug",
        "candidate",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "protagonist",
        "therapeutic",
        "inc",
        "protagonist",
        "therapeutic",
        "granted",
        "two",
        "new",
        "u",
        "patent",
        "peptide",
        "drug",
        "candidate",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}